P7C3 is primarily studied for its neuroprotective properties. It has shown promise in protecting neurons in various models of neurodegenerative diseases, including Parkinson’s and Alzheimer’s disease. The compound enhances neuronal survival by supporting mitochondrial function and promoting the generation of new neurons in the brain. It has been effective in preclinical studies at slowing cognitive decline and improving motor function. Due to its ability to cross the blood-brain barrier, P7C3 is considered a strong candidate for developing treatments for brain injuries and age-related cognitive impairment. Research is ongoing to explore its potential in stroke recovery and other central nervous system disorders.